Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-ma...

por Day, Douglas G, Walters, Thomas R, Schwartz, Gail F, Mundorf, Thomas K, Liu, Charlie, Schiffman, Rhett M, Bejanian, Marina
Publicado 2013

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

por Craven, E. Randy, Walters, Thomas, Christie, William C., Day, Douglas G., Lewis, Richard A., Goodkin, Margot L., Chen, Michelle, Wangsadipura, Veronica, Robinson, Michael R., Bejanian, Marina
Publicado 2019